Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 16, 2006
- Novartis Files NDA for Additional Indication of Glivec
January 16, 2006
- SURVEY 3 articles
January 16, 2006
- Peg-Intron, Rebetol Combination Granted Additional Indication
January 16, 2006
- Aricept Orodispersible Tablet Completes MRP in 12 EU Countries
January 16, 2006
- REGULATORY NEWS IN BRIEF
January 16, 2006
- Nippon Shinyaku Licenses CML Treatment NS-187 to INNOVIVE of the US
January 16, 2006
- BUSINESS NEWS IN BRIEF
January 16, 2006
- SELF-MEDICATION NEWS IN BRIEF
January 16, 2006
- More Drugs to Come from Bio-ventures than Drug Firms: Prof. Morishita of AnGes MG
January 16, 2006
- Pharma Industry Invested \906.7 Bil. in R&D in FY2004
January 16, 2006
- JMA to Support IIT through Training, Information Supply
January 16, 2006
- Mr Takeda of FPMAJ Stresses Importance of Market Price Principle
January 16, 2006
- R&D NEWS IN BRIEF
January 16, 2006
- General Account Budget Totaling \79,686 Bil. Proposed by MOF
January 9, 2006
- Concerns Expressed by Various Parties on Proposed NHI Pricing Reform -1-
January 9, 2006
- Concerns Expressed by Various Parties on Proposed NHI Pricing Reform -2-
January 9, 2006
- Society Working to Have MTX Approved for JIA
January 9, 2006
- Seminar on Drugs for Children: SJP
January 9, 2006
- REGULATORY NEWS IN BRIEF
January 9, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…